Brimonidine Eye Drops within the Reach of Children: A Possible Foe
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one case of transient encephalopathy in a toddler...
Saved in:
Main Authors: | Daniela Trotta (Author), Mirco Zucchelli (Author), Carmela Salladini (Author), Patrizia Ballerini (Author), Claudia Rossi (Author), Maurizio Aricò (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of brimonidine tartrate gel in the treatment of rosacea
by: Jackson JM, et al.
Published: (2015) -
About the pathways to deliver brimonidine to the Muller's muscle
by: Soha Ghanian, MD, et al.
Published: (2023) -
Topical brimonidine for pyogenic granuloma after paronychia surgery
by: Yusha Chen, MM, et al.
Published: (2021) -
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
by: Federica Conti, et al.
Published: (2021) -
The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
by: Ruiz Simonato Alonso, et al.
Published: (2020)